Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

271
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
271
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

419
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
419
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Evaluation of the CompreHensive geriAtRician-led MEdication Review (CHARMER) deprescribing intervention in hospital: protocol for a cluster randomised stepped-wedge trial.

BMJ open·2026
Same author

Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network.

ERJ open research·2026
Same author

Multi-modal integrated intervention combining exercise, anti-inflammatory, and dietary advice (MMIEAD) for adults with kidney cachexia: protocol for a mixed-methods feasibility cluster randomised controlled trial and process evaluation.

Pilot and feasibility studies·2026
Same author

Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: A systematic review and meta-analysis.

Clinical nutrition ESPEN·2026
Same author

A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis.

Health technology assessment (Winchester, England)·2026

Related Experiment Video

Updated: Aug 13, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Multimorbidity in bronchiectasis: a systematic scoping review.

Imogen Marsland1,2,3,4, Ruth Sobala3,4, Anthony De Soyza1,2,3,5

  • 1Population and Health Science Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

ERJ Open Research
|January 23, 2023
PubMed
Summary
This summary is machine-generated.

Multimorbidity, the presence of multiple chronic conditions, is common in bronchiectasis patients. Research gaps exist in understanding its impact on quality of life and management, despite links to increased mortality.

More Related Videos

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.7K
Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

1.5K

Related Experiment Videos

Last Updated: Aug 13, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K
Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.7K
Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
05:19

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

1.5K

Area of Science:

  • Respiratory Medicine
  • Public Health
  • Clinical Research

Background:

  • Multimorbidity, defined as the coexistence of two or more chronic conditions, is prevalent but poorly understood in bronchiectasis.
  • Existing research has primarily focused on specific comorbidities and their impact on prognosis.

Purpose of the Study:

  • To conduct a scoping review of existing literature on multimorbidity in bronchiectasis.
  • To identify research gaps concerning prevalence, prognosis, symptoms, quality of life, and management.

Main Methods:

  • A comprehensive literature search was performed across PubMed, CINAHL, and EMBASE databases.
  • PRISMA guidelines were followed, including observational, interventional, qualitative, RCTs, and systematic reviews.
  • Key findings were descriptively analyzed to synthesize current knowledge.

Main Results:

  • Forty studies involving over 200,000 patients were included, predominantly cohort studies.
  • Chronic Obstructive Pulmonary Disease (COPD), cardiovascular disease, and asthma were the most frequent comorbidities.
  • Multimorbidity was significantly associated with increased mortality, exacerbations, hospitalizations, and reduced lung function.

Conclusions:

  • Multimorbidity is a significant issue in bronchiectasis, frequently involving COPD and hypertension.
  • There is a critical need for more research into the symptoms, quality of life, and management of patients with bronchiectasis multimorbidity.
  • Current diagnostic and screening methods for multimorbidity in bronchiectasis lack standardization.